Monday, Apr 29, 2024 | Last Update : 12:32 AM IST

plasma cells

This drug ups risk of heart failure in cancer patients

The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma.

30 Dec 2017 6:45 PM

ADVERTISEMENT
ADVERTISEMENT